Novo Nordisk Inc., a Danish pharmaceutical manufacturer, has agreed to pay $25 million to resolve its civil liability arising from the illegal promotion of its hemostasis management drug, NovoSeven.

A Food and Drug Administration (FDA) chemist pleaded guilty today before U.S. District Court Judge Deborah K. Chasanow in the District of Maryland to one count of securities fraud and one count of making false statements, related to a $3.7 million insider trading scheme that spanned nearly five years.

"The work of the Justice Department on health care fraud is part of a comprehensive approach this Administration has taken toward improving the Nation’s overall health care delivery system; an approach that aims to secure better, quality coverage at lower costs for all of us," said Assistant Attorney General West.

American pharmaceutical company Merck, Sharp &.

KV Pharmaceutical Company, which was the St. Louis-based parent company of now-defunct Ethex Corporation, will pay $17 million to resolve False Claims Act allegations that Ethex failed to advise the Centers for Medicare and Medicaid Services (CMS) that two unapproved products did not qualify for coverage under federal health care programs, the Justice Department announced today.

The United States has filed a consent decree for permanent injunction against the generic drug manufacturer Ranbaxy Laboratories Ltd., an Indian corporation, in the U.S. District Court for the District of Maryland, the Department of Justice announced today.

Dava Pharmaceuticals Inc. has agreed to pay the United States $11 million to settle allegations that it violated the False Claims Act by misreporting drug prices in order to reduce its Medicaid Drug Rebate obligations, the Justice Department announced today.

Mississippi-based Cypress Pharmaceutical Inc., its subsidiary Hawthorn Pharmaceuticals Inc. and its CEO, Max Draughn, have agreed to pay $2.8 million to resolve civil allegations under the False Claims Act, the Justice Department announced today.

American pharmaceutical company Merck, Sharp & Dohme was sentenced by U.S. District Court Judge Patti B. Saris in Boston to pay a criminal fine in the amount of $321,636,000 in connection with its guilty plea related to its promotion and marketing of the painkiller Vioxx (rofecoxib), the Justice Department announced today.

The Department of Justice announced the guilty plea and sentencing of Easley, S.C.-based Aletec Medical for engaging in a multi-million dollar prescription drug scheme. Altec Medical pleaded guilty in U.S. District Court in Miami to one count of conspiring to defraud the U.S. Food and Drug Administration (FDA) and to commit federal offenses in connection with a drug-diversion scheme that lasted from 2007 to 2009.

Andrew Strempler, a Canadian citizen, pleaded guilty today in the Southern District of Florida for his role in a scheme to defraud consumers purchasing pharmaceuticals online, the Justice Department announced. Strempler faces up to five years in prison, a forfeiture of $300,000, a fine and restitution.

Two Pakistani nationals have been indicted by a federal grand jury in the District of Columbia on charges alleging that they operated Internet sites that illegally shipped pharmaceuticals from Pakistan and the United Kingdom to customers in the United States.

A Canadian citizen was sentenced to 48 months in prison today for his role in a scheme to defraud consumers purchasing pharmaceuticals online, the Justice Department announced. Andrew J. Strempler was also ordered to pay a forfeiture of $300,000, a fine of $25,000 and restitution.

New Jersey-based Par Pharmaceutical Companies Inc. pleaded guilty in federal court today and agreed to pay $45 million to resolve its criminal and civil liability in the company’s promotion of its prescription drug Megace ES for uses not approved as safe and effective by the Food and Drug Administration and not covered by federal health care programs.

Teva Pharmaceuticals USA Inc. has agreed to pay a $2.25 million civil penalty to settle alleged violations of the federal Clean Air Act (CAA), Clean Water Act (CWA), and the Resource Conservation and Recovery Act (RCRA), as well as the Missouri Air Conservation Law, Clean Water Law and Hazardous Waste Management Law at its facility in Mexico, Mo.

The Justice Department announced today that the United States has filed a second civil false claims lawsuit against Novartis Pharmaceuticals Corp. involving alleged kickbacks paid by the company to health care providers.

Pharmaceutical company ISTA Pharmaceuticals, Inc. pled guilty earlier today to conspiracy to introduce a misbranded drug into interstate commerce and conspiracy to pay illegal remuneration in violation of the Federal Anti-Kickback Statute.

Acting Assistant Attorney General Stuart F. Delery announced today that the Department of Justice, on behalf of the Food and Drug Administration (FDA), has filed suit in the U.S. District Court for the Western District of Louisiana against Sage Pharmaceuticals.

King Pharmaceuticals LLC (King) will pay $2.2 million and take measures to comply with the Clean Air Act to resolve alleged violations of the Clean Air Act (CAA) at its pharmaceutical manufacturing facility located in Bristol, Tenn.

Wyeth Pharmaceuticals Inc., a pharmaceutical company acquired by Pfizer, Inc. in 2009, has agreed to pay $490.9 million to resolve its criminal and civil liability arising from the unlawful marketing of the prescription drug Rapamune for uses not approved as safe and effective by the U.S. Food and Drug Administration (FDA).

"Why is health care enforcement so important? A major reason is the importance of the health care industry itself. From compliance officers to physicians, from corporate executives to nurses and researchers, you contribute to producing the drugs and medical devices on which we and our loved ones rely. Your efforts help to ensure that, when we are sick, the medicines we take will heal us effectively; that when we are in pain, we can obtain relief safely," said Assistant Attorney General Delery

Pharmaceutical company Endo Health Solutions Inc. and its subsidiary Endo Pharmaceuticals Inc. (Endo) have agreed to pay $192.7 million to resolve criminal and civil liability arising from Endo’s marketing of the prescription drug Lidoderm for uses not approved as safe and effective by the Food and Drug Administration.

Pharmaceutical manufacturer Teva Pharmaceuticals USA Inc. and a subsidiary, IVAX LLC, have agreed to pay the government and the state of Illinois $27.6 million for allegedly violating the False Claims Act by making payments to induce prescriptions of an anti-psychotic drug for Medicare and Medicaid beneficiaries.

The Department of Justice today announced the filing of a civil lawsuit against Laclede Inc. and its president, Michael A. Pellico, seeking to stop the distribution of over-the-counter vaginal drug products that the company makes and sells nationwide

A Wisconsin pharmacist and a Nevada pharmacologist were arraigned on an indictment today in Federal Court in Central Islip, New York, before United States Magistrate Judge Gary Brown. The defendants are charged with conspiring to supply at least four million misbranded and counterfeit pharmaceuticals to an illegal Internet pharmacy based in Costa Rica that catered to U.S. customers.

From : Communities>>Regulatory Open Forum
Hi everyone, As currently drafted,  the 2020 Chinese Pharmacopeia, the benchmark publication on the safety and efficacy of pharmaceuticals legally available in China, includes 319 new entries. The publication includes more than 5,500 traditional Chinese and Western medicines. The official compendium of the standards of purity, description, test, dosage, precaution, storage, and the strength for each drug legally marketed in China is published by the Chinese Pharmacopoeia Commission. It is designed [More]

There is going to be a time in the not too distant future, when the fuller picture of the healthcare impacts of COVID-19 come into sharper focus. When that happens, it is not likely to be pretty. In large part, … Continue reading →

Modern innovation typically occurs one step-improvement at a time. Some clients initially question whether their new application of an existing technology is patentable. Usually, the answer is ‘yes.’ Under U.S. law (and most other jurisdictions), an innovation to an existing technology is patentable so long as at least one claim limitation is novel and non-obvious....… Continue Reading

Current water treatment can't remove these wastes that are increasingly implicated in serious environmental effects

Scientists say levels are dangerously high, affecting wildlife and ecosystems.

Ask About the Curve Public Service Announcement

The Park Family’s Infertility Story

West and HealthPrize are collaborating to provide an end to end connected health solution for pharmaceutical companies and the patients they serve.

Ask About the Curve Public Service Announcement

Kare Schultz, CEO of Teva Pharmaceuticals, joins "Squawk on the Street" to discuss the coronavirus pandemic and treatment.

As the number of confirmed COVID-19 cases worldwide approaches 4 million and the pandemic could be with us for months or years, we look at who can access drugs like remdesivir, being developed by pharmaceutical giant Gilead, which has the patent for the drug and is poised to make massive profits. We look at how much drugs like remdesivir will cost, and who can access them, with writer Achal Prabhala, coordinator of the AccessIBSA project, which campaigns for access to medicines in India, Brazil and South Africa.

Company: Confidential
Qualification: Bachelor Of Pharmacy (B.Pharm), Master of Pharmacy (M.Pharm)
Experience: 4 to 8
Salary: 3.20 to 4.70
location: Delhi
Ref: 24798194
Summary: Urgent Opening for the profile of Medical Representative pharmaceutical in Sanitizer Co.

Of pharmaceutical products, health care products packaging theory , there are several aspects of the law we need to , inter alia: 1 , generate new theory of pharmaceutical products , not only to consider the psychological factors of...

Imports (Bop) - Pharmaceutical And Medicinal Products in Canada increased to 1826.70 CAD Million in March from 1786.80 CAD Million in February of 2020. Imports (Bop) - Pharmaceutical And Medicinal Produ in Canada averaged 772.14 CAD Million from 1988 until 2020, reaching an all time high of 2084 CAD Million in December of 2019 and a record low of 80.90 CAD Million in April of 1989. This page includes a chart with historical data for Canada Imports of (bop) - Pharmaceutical And Medicinal P.

This paper looks at recent trends in pharmaceutical spending across OECD countries. It examines the drivers of recent spending trends, highlighting differences across therapeutic classes, and then looks at emerging challenges for policy makers in the management of pharmaceutical spending.

Imports of Intra EU - Pharmaceutical Products in the United Kingdom decreased to 1002.66 GBP Million in February from 1303.57 GBP Million in January of 2020. Imports of Intra EU - Pharmaceutical Products in the United Kingdom averaged 746.54 GBP Million from 1996 until 2020, reaching an all time high of 2706.48 GBP Million in March of 2019 and a record low of 119.69 GBP Million in April of 1996. This page includes a chart with historical data for the United Kingdom Imports of Intra EU - Pharmaceutical Products.

Exports of Pharmaceuticals in France increased to 3874 EUR Million in March from 2668 EUR Million in February of 2020. Exports of Pharmaceuticals in France averaged 2022.39 EUR Million from 2000 until 2020, reaching an all time high of 3874 EUR Million in March of 2020 and a record low of 918 EUR Million in April of 2000. This page includes a chart with historical data for France Export: Pharmaceuticals.

Exports - Pharmaceuticals, Vitamin, Diagnostic Product in Switzerland increased to 10314.12 CHF Million in March from 7828.12 CHF Million in February of 2020. Exports - Pharmaceuticals, Vitamin, Diagnostic Pro in Switzerland averaged 6977.56 CHF Million from 2014 until 2020, reaching an all time high of 10314.12 CHF Million in March of 2020 and a record low of 4831.40 CHF Million in December of 2014. This page includes a chart with historical data for Switzerland Exports of Pharmaceuticals, Vitamin, Diagnostic P.

Imports of Pharmaceuticals in China decreased to 3138000 USD THO in April from 3840100 USD THO in March of 2020. Imports of Pharmaceuticals in China averaged 2209862.09 USD THO from 2014 until 2020, reaching an all time high of 5043700 USD THO in February of 2020 and a record low of 1078115 USD THO in February of 2015. This page includes a chart with historical data for China Imports of Pharmaceuticals.

While human travel has become severely restricted in recent months, the movement of goods has remained a constant priority — and in some cases, has become even more urgent. Today, a startup out of Switzerland that builds hardware and operates a logistics network designed to transport one item in particular — pharmaceuticals — is announcing […]

Dexter Blackstock has gone from football to pharmaceuticals - and hopes to save lives, slash the cost of healthcare and even help change the perception of professional players.

Cham : Springer, [2019]